Close
Nordic 9Nordic 9

21stBio (investor - Corporate Investor)

Denmark nordic9.com
See something wrong or missing? Let us know
Offices:Copenhagen
Average round investment:20M USD
Average number per year:1.0
Distribution: 2024 (1)
Portfolio companies: Denmark Reshape Biotech
Mostly invests in: Denmark Denmark (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to 21stBio

Name Criteria
Denmark Per Falholt
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Manufacturing, Robotics
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States R7 Partners
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing, Robotics
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States ACME Capital
82%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Manufacturing, Robotics
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
United Kingdom Manta Ray
81%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Manufacturing, Robotics
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
United States Walden Catalyst Ventures
80%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing, Robotics
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Invus
80%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing, Robotics
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Germany Pace Ventures
80%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Manufacturing, Robotics
  • Similar business models: B2B
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Belgium European Investment Fund
80%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing, Robotics
  • Similar business models: B2B
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Germany MIG Verwaltungs AG
79%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Manufacturing, Robotics
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
Hong Kong Happiness Capital
79%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing, Robotics
  • Similar business models: B2B
  • Average number of deals per year: 2.8
  • Active last 12 months: Yes
Top